KC
XENT

Kryger Capital’s Intersect ENT, Inc XENT Stock Holding History

Kryger Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-453,076
Closed -$12.7M – 256
2022
Q1 		$12.7M Buy
453,076
+11,238
+3% +$308K 0.73% 22
2021
Q4 		$12.1M Buy
+441,838
New +$12M 0.68% 19

Kryger Capital's XENT Position: Q2 2022 in Review

Kryger Capital sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 453,076 shares — an estimated $12.7M sold.

Kryger Capital first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $12.7M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Kryger Capital reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Kryger Capital sold 453,076 Intersect ENT, Inc shares in Q2 2022, an estimated $12.7M.
  • Kryger Capital first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • Kryger Capital's Intersect ENT, Inc position peaked at $12.7M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Kryger Capital's 13F filing for Q2 2022, filed 15 Aug 2022.